Wordt geladen...
Cerebral Amyloid Angiopathy: A Hidden Risk for IV Thrombolysis?
Recombinant tissue plasminogen activator (t-PA) is the only FDA approved therapy for acute ischemic stroke. Cerebral microbleeds (CMBs) or cerebral amyloid angiopathy (CAA) are currently not contraindications, however, data regarding this complex issue are limited. We report 2 cases of fatal intrace...
Bewaard in:
| Gepubliceerd in: | J Neurol Transl Neurosci |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4536831/ https://ncbi.nlm.nih.gov/pubmed/26280025 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|